Literature DB >> 23112382

'A most protean disease': aligning medical knowledge of modern influenza, 1890-1914.

Michael Bresalier1.   

Abstract

This article reconstructs the process of defining influenza as an infectious disease in the contexts of British medicine between 1890 and 1914. It shows how professional agreement on its nature and identity involved aligning different forms of knowledge produced in the field (public health), in the clinic (metropolitan hospitals) and in the laboratory (bacteriology). Two factors were crucial to this process: increasing trust in bacteriology and the organisation of large-scale collective investigations into influenza by Britain's central public authority, the Medical Department of the Local Government Board. These investigations integrated epidemiological, clinical and bacteriological evidence into a new definition of influenza as a specific infection, in which a germ - Bacillus influenzae - was determined as playing a necessary but not sufficient role in its aetiology, transmission and pathogenesis. In defining 'modern influenza', bacteriological concepts and techniques were adapted to and selectively incorporated into existing clinical, pathological and epidemiological approaches. Mutual alignment thus was crucial to its construction and, more generally, to shaping developing relationships between laboratory, clinical and public health medicine in turn-of-the-century Britain. While these relationships were marked by tension and conflict, they were also characterised by important patterns of convergence, in which the problems, interests and practices of public health professionals, clinicians and laboratory pathologists were made increasingly commensurable. Rather than retrospectively judge the late nineteenth-century definition of influenza as being based on the wrong microbe, this article argues for the need to examine how it was established through a particular alignment of medical knowledge, which then underpinned medical approaches to the disease up to and beyond the devastating 1918-19 pandemic.

Entities:  

Mesh:

Year:  2012        PMID: 23112382      PMCID: PMC3483746          DOI: 10.1017/mdh.2012.29

Source DB:  PubMed          Journal:  Med Hist        ISSN: 0025-7273            Impact factor:   1.419


  7 in total

1.  Linking cause and disease in the laboratory: Robert Koch's method of superimposing visual and 'functional' representations of bacteria.

Authors:  T Schlich
Journal:  Hist Philos Life Sci       Date:  2000       Impact factor: 1.205

2.  Social epistemology and the ethics of research.

Authors:  David Resnik
Journal:  Stud Hist Philos Sci       Date:  1996-12       Impact factor: 1.429

3.  Scientific triumphalism and learning from facts: bacteriology and the "Spanish flu" challenge of 1918.

Authors:  Eugenia Tognotti
Journal:  Soc Hist Med       Date:  2003-04       Impact factor: 0.973

4.  A Study of Influenza; and the Laws of England Concerning Infectious Diseases.

Authors:  R Sisley
Journal:  Br Med J       Date:  1892-01-23

5.  The laboratory and the clinic: the impact of pathology on surgical diagnosis in the Glasgow Western Infirmary, 1875-1910.

Authors:  L S Jacyna
Journal:  Bull Hist Med       Date:  1988       Impact factor: 1.314

6.  The conceptualization of influenza in eighteenth-century Britain: specificity and contagion.

Authors:  M DeLacy
Journal:  Bull Hist Med       Date:  1993       Impact factor: 1.314

7.  On the cusp: epidemiology and bacteriology at the local government board, 1890-1905.

Authors:  A Hardy
Journal:  Med Hist       Date:  1998-07       Impact factor: 1.419

  7 in total
  2 in total

1.  "The Most Disastrous and Fatal Epidemic": Mortality Statistics During the 1890 Russian Influenza Epidemic in Connecticut.

Authors:  E Thomas Ewing
Journal:  Public Health Rep       Date:  2021-03-15       Impact factor: 2.792

2.  La Grippe or Russian influenza: Mortality statistics during the 1890 Epidemic in Indiana.

Authors:  E Thomas Ewing
Journal:  Influenza Other Respir Viruses       Date:  2019-02-12       Impact factor: 4.380

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.